West Pharmaceutical Services Inc (STU:WPS)
€ 312 1.9 (0.61%) Market Cap: 22.88 Bil Enterprise Value: 22.71 Bil PE Ratio: 48.90 PB Ratio: 8.68 GF Score: 90/100

West Pharmaceutical Services Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 23, 2022 / 01:00PM GMT
Release Date Price: €366.6 (+0.55%)
Paul Richard Knight
KeyBanc Capital Markets Inc., Research Division - MD & Senior Analyst

Good morning. This is Paul Knight, Analyst at Keybanc Capital Markets on the Life Science Industry. We have with us today West Pharmaceutical, Eric Green, CEO; Bernard Birkett, Chief Financial Officer; and Quintin Lai, who's Director of Investor Relations.

The format is going to be -- I think Eric is going to have a few opening comments. If you have questions, you can ask them any time. There's a chat you can put those questions into or on my e-mail [email protected].

And with that, Eric, we appreciate your time today. And I'll let you start it off.

Eric M. Green
West Pharmaceutical Services, Inc. - Chair, President & CEO

Yes. Great. Well, good morning, Paul, and good morning, everyone. Thank you for the invitation to be able to come together and talk about West and where we are, but more importantly, where we're going. It's an exciting time here at West. Obviously, we'll probably talk a little bit further in the Q&A session around the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot